More Science, More Networking, More Everything in 2024
SOT is returning to Salt Lake City for the first time in more than a decade for its 63rd Annual Meeting and ToxExpo. The 2024 meeting will feature five days of Featured and Scientific Sessions, poster presentations, and social events, as well as the popular three-day ToxExpo.
Medicilon is excited to attend and exhibit at the conference. Dr. Haizhou Zhang, president of preclinical R&D unit at Medicilon, will be available at the booth. Dr. Zhang holds a PhD in Toxicology from Indiana University, USA. He is a pharmaceutical industry veteran with over 20 years of experience in the R&D of small and large molecule drugs.
We are getting ready. Are you?
Date: March 10-14, 2024
Location: Salt Palace Convention Center, Salt Lake City, Utah
Medicilon Booth: 1408
Medicilon Toxicology Studies Services
Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.
By the end of 2023, we have served more than 2000 clients globally with more than 300 INDs approved in China and more than 80 INDs approved overseas using toxicology data generated by Medicilon.